AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Legis1

Published November 13, 2026 · Updated November 14, 2026

House Panel Will Examine Veterans' Psychedelic Therapy - Legis1

Read the full story at Legis1

Committee member Rep. Jack Bergman (R-MI-1) has a profile saying he joined a bipartisan push for Food and Drug Administration approval of MDMA -.

Post on X

Share this story

Surfaced by this Google Alert

MDMA